Small Cap Feast
Small Cap Feast – 9th August 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 887
Total number of AIM Companies trading: 804*
* As at 26 July 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 86*
Total number of NEX Growth Market Companies trading: 84*
* As at 26 July 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 166*
Total number of Standard List Companies trading: 144*
* As at 26 July 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Freyherr International Group PLC the Medicinal Cannabis holding company established in 2016, is planning to list on the NEX exchange on the 13 August.
Providence Res. (PVR.L) 8.95p £52.30m
Providence Resources, the Irish based Oil and Gas Energy company, today provides an operational update in relation to Standard Exploration Licence 1/11 which contains the Barryroe oil accumulation.
The Barryroe Partners have now confirmed that they have received permission from the Minister of State at the Department of Communications, Climate Action and Environment to undertake a seabed debris clearance, environmental baseline and habitat assessment site survey over the area of the Barryroe field within SEL 1/11. Pursuant to the terms of the Updated Farm-out Agreement with APEC (as amended), and subject to the receipt of funding from APEC or alternative financing arrangements being put in place, the site survey is expected to commence later this month.
Hikma Pharmaceuticals (HIK.L) 1959.00p £4,460.35m
Hikma Pharmaceuticals, the generic drugmaker, has raised its full-year expectations after new product launches boosted first-half profits.
For the six months ended 30 June, the FTSE 250 firm reported a core profit attributable to shareholders of US$176mln, 19% higher year-on-year, while core revenues rose 7% to US$1.04bn. As a result of its strong first half, the company said it now expected full-year revenues from its Injectables business to be between US$870mln-US$900mln, compared to US$850mln-US$900mln in a May trading update, while its Generics business was now forecast to deliver between US$690mln-US$720mln compared to previous estimates of between US$650mln-US$700mln.
“All of our businesses are performing well. We are delivering more from our unique and diversified business model, leading market positions and high-quality operations to drive strong organic growth”, said Siggi Olafsson, Hikema’s chief executive.
Equals Group (EQLS.L) 117.50p £193.07m
Equals Group PLC, the e-banking and international payments group, announced that its subsidiary, FairFX, has acquired the International Payments business of Hermex International, part of the FXPro Group, for a total consideration of £2 million, payable in cash on completion.
HermexFX offers international payment services to a predominantly corporate client base through a personalised service offering. The Acquisition will complement the Group’s strategy to develop its fast-growing corporate segment, providing additional corporate clients and cross-selling opportunities for the expanding range of products through their existing sales channels. The Group’s technology, combined with its expertise in compliance, operations and settlements, means the integration of the HermexFX business into the Group can be achieved efficiently.
The Acquisition is made in accordance with the Group’s strategy to consolidate smaller, attractive market participants. It is expected to be immediately earnings enhancing. In addition, the Acquisition fits with one of Equals’ stated core strategies of extracting value from increasing economies of scale.
Xtract Resources (XTR.L) 1.25p £4.26m
Xtract Resources, a diversified metals and minerals producer, announced that the Company’s technical consultants have provided an informal report to the Company on the integration of the previous exploration databases and undertaken an interim review of drill targets over the Eureka project on the copper-gold small scale mining licence number 22134-HQ-SML located in the Central part of The Republic of Zambia.
The historic data overview confirmed targets for fast-track drilling. Two copper (+ gold) soil anomalies were highlighted, the largest extending for 3km. The main anomaly peaks at 1,315ppm Cu, 540ppb Au in the vicinity of the previous worked shallow open pit mine. The drilling review indicates mineralisation in Eureka pit area remains open, with particular focus to the southeast and to depth. The near-term drill targets selected subject to surveying of historic drill hole collars and preparatory ground work.
Alexander Mining (AXM.L) 0.03p £0.80m
Alexander Mining, the mining, minerals and metals processing technology company, announced that it has successfully placed 2,375,000,000 ordinary shares of 0.001 pence each at a price of 0.02p per share, raising £475,000 before expenses, through its sole broker and placing agent Turner Pope Investments.
The net proceeds of the Placing will be used for general working capital and business development purposes.
Commenting on the Placing, Martin Rosser, CEO of Alexander, said “We are delighted to have secured this investment from new and existing shareholders to give the Company the flexibility for a potential beneficial corporate opportunity and to provide additional working capital. Also, we are delighted about the proposed board appointment of Nigel Burton and the extensive experience that he will bring to the Company.”
Rambler Metals and Mining (RMM.L) 1.40p £16.53m
Rambler Metals and Mining, a copper and gold producer, explorer, and developer, announced that for the fiscal quarter ending June 30, 2019 it achieved record throughput by processing 112,679 tonnes of ore from the Ming Mine through the Nugget Pond copper and gold milling facility.
This supported a 45% increase in saleable copper produced in concentrate and 10% increase in saleable gold produced in concentrate relative to the same year-ago quarter. Additionally, first half (H1) 2019 record throughput of 211,090 tonnes of ore from the Ming Mine and through the Nugget Pond copper and gold milling facility has supported a 46% increase in saleable copper produced in concentrate and 32% increase in saleable gold produced in concentrate relative to the first half of 2018.
IXICO (IXI.L) 36.50p £18.01m
IXICO, the data analytics company delivering insights in neuroscience, today announced an update on contracts:
Two new biopharmaceutical client contracts with combined value of over £1m
Award of a significant change order to Phase III Huntington’s disease contract worth c£0.9 million
Discontinuation of a study with no impact on FY19 revenue; reduction of contract revenue of £3.5m over the full term of the agreement to 2025
Confirms confidence in the current year market expectations and the outlook for next year
The Company has secured contracts (with a combined contract value of over £1m) with two new biopharmaceutical clients for the provision of data analytics services to support clinical trials taking place in North America and Europe.
Gordon Dadds Group (GOR.L) 144.50p £53.43m
Gordon Dadds Group, a law and professional services firm, today completed the review of their future operations in Monaco:
On 31 December 2018, the Group acquired the former Ince & Co LLP which included the firm’s London, Beijing and Shanghai offices.
On 1 April 2019, the Group entered into new arrangements with the independent legal entities which were former Ince & Co network firms in Hong Kong, Singapore, Dubai, Greece and Germany and whose results will now be consolidated in the Group’s results, while continuing to review its relationship with the former Ince office in Monaco.
The outcome of this review process is that the Group has concluded that the financial performance of its representation in Monaco can be improved by bringing in a new team. As a result, in future, the Monaco office, under the new team, will become part of the Group. The former Ince team will leave that firm shortly.
Pennant International Group (PEN.L) 51.50p £27.99m
Pennant International Group, the supplier of integrated training and support solutions, products and services announced a trading update for the six months ended 30 June 2019.
The Company expects to report results for the First Half which are slightly better than management’s expectations, with revenues of £7.25 million and an EBITA loss of £(1.49) million. Net cash stood at approximately £(0.35) million at the end of H1 2019.
Porta Communications (PTCM.L) 0.53p £2.66m
Porta Communications, a communications, marketing, design, advertising and analytical services consultancy, announced that Rhydian Bankes is stepping down from the Board and as Chief Financial Officer of the Group with immediate effect and will remain with the Group until 1 November 2019.
He will continue to assist with the completion of the merger of the Group with SEC S.p.A., which is expected to become effective on 3 September 2019, and the orderly transfer of his responsibilities.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.